Screener
MoonLake Immunotherapeutics MLTX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 8:55 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001821586-26-000007
| (in thousands, except share and per share data) | March 31, 2026 (Unaudited) | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 15) | ||
| Shareholders' equity | ||
| Class A Ordinary Shares: $0.0001 par value per share; 500,000,000 shares authorized; 72,134,066 shares issued and outstanding as of March 31, 2026; 71,373,579 shares issued and outstanding as of December 31, 2025 | 7 | 7 |
| Additional paid-in capital | 786,313 | 766,781 |
| Accumulated deficit | (532,618) | (462,911) |
| Accumulated other comprehensive income | 322 | 604 |
| Total shareholders’ equity | 254,024 | 304,481 |
| Total liabilities and shareholders' equity | $400,374 | $424,433 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is MoonLake Immunotherapeutics's total liabilities & equity?
- MoonLake Immunotherapeutics (MLTX) reported total liabilities & equity of $400.37M in Q1 2026.
- How has MoonLake Immunotherapeutics's total liabilities & equity changed year-over-year?
- MoonLake Immunotherapeutics's total liabilities & equity decreased by 21.7% year-over-year, from $511.26M to $400.37M.
- What is the long-term trend for MoonLake Immunotherapeutics's total liabilities & equity?
- Over 5 years (2020 to 2025), MoonLake Immunotherapeutics's total liabilities & equity has grown at a 29.5% compound annual growth rate (CAGR), from $116.63M to $424.43M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about MoonLake Immunotherapeutics's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude